A powerful new addition to existing therapies
Eyerising International’s commitment to leading the fight against childhood myopia led to the development of our patented Eyerising Myopia Management Device Repeated Low-Level Red-Light (RLRL) therapy, a highly effective and child-friendly way to treat myopia.
The device is clinically proven to slow the progression of child myopia by up to 87.7%7. It is designed to be used at home with 3 minutes of treatment, twice a day, 5 days per week and a minimum of 4 hours between sessions. All without pain, complications or known significant side effects.